IMRA moved above its 50-day moving average on September 24, 2026 date and that indicates a change from a downward trend to an upward trend. In 21 of 22 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
The 10-day moving average for IMRA crossed bullishly above the 50-day moving average on September 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Aroon Indicator entered an Uptrend today. In 96 of 123 cases where IMRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The 50-day moving average for IMRA moved below the 200-day moving average on September 08, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
a company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies
Category Unknown